Related Experiment Video
Updated: Jul 11, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion
Daniela Marotto1, Marta Moschetti2, Alessia Lo Curto2
1Rheumatology Unit, ASL Gallura, 07026 Olbia, Italy.
Abstract:
Pompe disease (PD), also defined as acid maltase deficiency, is a rare autosomal recessive disease that causes glycogen accumulation due to a deficiency of the lysosomal enzyme acid α-glucosidase. An excessive amount of undisposed glycogen causes progressive muscle weakness throughout the body. It particularly affects skeletal muscles and the nervous system, especially in the late-onset phase. Here, we present a clinical case of late-onset PD (LOPD) with normal CK (creatinine kinase) values treated after a misdiagnosis of demyelinating motor polyneuropathy and chronic inflammatory neuropathy. The suspicion of possible fibromyalgia induced the patient to seek a rheumatology consultation, and the investigations performed led to the diagnosis of PD. The patient was investigated for genetic and enzymatic studies. PD was diagnosed using the α-glucosidase assay on DBS. In LOPD, clinical manifestations, such as muscle weakness, exercise intolerance, myalgia, or even high hyperCKemia, often appear as nonspecific and may mimic a wide variety of other muscle disorders, such as limb muscle dystrophies, congenital, metabolic, or inflammatory myopathies. In our case, the patient had CK values in the normal range but with continued complaints typical of PD. An analysis of enzyme activity revealed a pathologic value, and genetic analysis identified the c.-32-13T>G mutation in homozygosis. The association of the pathological enzyme value and mutation in homozygosity with LOPD led to a familial segregation study. Our results contribute to the characterization of PD in Italy and support the importance of rheumatologic attention. This suggests further studies are needed to define the broad clinical and pathological spectrum observed in this disease.
Insights
Late-onset Pompe disease (LOPD) can present with normal creatinine kinase (CK) levels, mimicking other neuromuscular disorders. Early diagnosis requires enzyme and genetic testing for effective treatment.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Pompe disease (PD), or acid maltase deficiency, is a rare genetic disorder.
- It results from a deficiency in the lysosomal enzyme acid α-glucosidase, leading to glycogen buildup.
- This accumulation causes progressive muscle weakness, particularly affecting skeletal muscles and the nervous system in late-onset PD (LOPD).
Observation:
- This case study details a patient with LOPD who presented with normal creatinine kinase (CK) levels.
- The patient was initially misdiagnosed with demyelinating motor polyneuropathy and chronic inflammatory neuropathy.
- Symptoms initially suggested fibromyalgia, leading to a rheumatology consultation.
Findings:
- Pompe disease was diagnosed via an α-glucosidase assay on dried blood spots (DBS).
- Enzyme activity was pathologically low, and genetic analysis revealed the c.-32-13T>G mutation in homozygosis.
- Despite normal CK levels, the patient exhibited characteristic LOPD symptoms.
Implications:
- This case highlights the diagnostic challenges of LOPD, especially with normal CK values.
- It underscores the importance of considering PD in patients with nonspecific neuromuscular symptoms.
- Further research is needed to fully understand the diverse clinical spectrum of Pompe disease.
More Related Videos
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Lysosomal Hydrolases
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests